Phase 4
N=20
Absorption Comparison on Equivalency Value of Genepro Gen2
Analysis, Event History · Absorption; Disorder, Protein
Bottom Line
View on ClinicalTrials.gov: NCT02919657 ↗Enrolled (actual)
20
Serious AEs
—
Results posted
Dec 2016
Primary outcome: Primary: Weekly Blood Draws to Measure Blood Protein Levels — 7.23; 6.86; 7.43; 7.21 grams per deciliter
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Genepro Protein (Dietary_supplement); Whey Protein (Dietary_supplement)
- Age
- Adult · 30+ yrs
- Sex
- All
- Sponsor
- Musclegen Research, Inc.
- Primary completion
- Sep 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Weekly Blood Draws to Measure Blood Protein Levels |
7.23; 6.86; 7.43; 7.21; 7.1; 7.28 | — |
Summary
Genepro Gen2 Absorption and Protein Value Clinical Trial.
Eligibility Criteria
- 20 Post Op Gastric Bypass patients.
- 10 men,
- 10 women.
- Minimum age 30
- Maximum age 46
- All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.
Exclusion Criteria
- Any digestive distress disorder (IBS, Crones, etc).
Data sourced from ClinicalTrials.gov (NCT02919657). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.